Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
Pajaree Krisanapan, Kanokporn Sanpawithayakul, Pattharawin Pattharanitima, et al.
Diseases (2024) Vol. 12, Iss. 1, pp. 14-14
Open Access | Times Cited: 9

Showing 9 citing articles:

Integrated Management of Cardiovascular–Renal–Hepatic–Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1-RAs
Nikolaos Theodorakis, Maria Nikolaou
Biomedicines (2025) Vol. 13, Iss. 1, pp. 135-135
Open Access | Times Cited: 6
Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
Takanobu Takata, Shinya Inoué, Kenshiro Kunii, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Hsuan-Wen Lai, Chun Yin See, Jui‐Yi Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Cardiovascular and Kidney Outcomes of Glucagon-Like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Nicole Felix, Mateus de Miranda Gauza, Vinicius Bittar, et al.
Cardiorenal Medicine (2025) Vol. 15, Iss. 1, pp. 98-107
Open Access
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
Oscar Resnick, Fernando Bril, Giovanna Beauchamp
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
Yu-qiong Lin, Yu Feng, Huijun Chen, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 2
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity
Daria Abasheva, Alberto Ortíz, Beatriz Fernández‐Fernández
Clinical Kidney Journal (2024) Vol. 17, Iss. Supplement_2, pp. 19-35
Open Access
Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus, With or Without Cardiovascular Disease: A Systematic Review and Meta-Analysis of 10,013 Patients
Adarsh Raja, Asfia Qammar, Satesh Kumar, et al.
American Journal of Therapeutics (2024)
Closed Access
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Kidney Disease: From Bench to Bed-Side
Aly M. Abdelrahman, Alaa S. Awad, Irtiza Hasan, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7732-7732
Open Access
Page 1

Scroll to top